[HTML][HTML] Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers

S Chalmers, A Khawaja, PM Wieruszewski… - World journal of …, 2019 - ncbi.nlm.nih.gov
Pneumonia and acute respiratory distress syndrome are common and important causes of
respiratory failure in the intensive care unit with a significant impact on morbidity, mortality …

[Translated article] Biological Biomarkers in Respiratory Diseases

F García-Río, B Alcázar-Navarrete… - Archivos de …, 2022 - Elsevier
In recent years, personalized or precision medicine has made effective inroads into the
management of diseases, including respiratory diseases. The route to implementing this …

Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017

S Athlin, C Lidman, A Lundqvist, P Naucler… - Infectious …, 2018 - Taylor & Francis
Based on expert group work, Swedish recommendations for the management of community-
acquired pneumonia in adults are here updated. The management of sepsis-induced …

Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie–Update 2021

S Ewig, M Kolditz, M Pletz, A Altiner, W Albrich… - …, 2021 - thieme-connect.com
Die vorliegende Leitlinie umfasst ein aktualisiertes Konzept der Behandlung und Prävention
von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die bisherige …

Biomarker guided antibiotic stewardship in community acquired pneumonia: A randomized controlled trial

R Duijkers, HJ Prins, M Kross, D Snijders… - Plos one, 2024 - journals.plos.org
Background In community-acquired pneumonia (CAP), the role of biomarkers to shorten
duration of antibiotic treatment has not been firmly established. We assessed the …

C-reactive protein as a predictor of survival and length of hospital stay in community-acquired pneumonia

A Travlos, A Bakakos, KF Vlachos, N Rovina… - Journal of Personalized …, 2022 - mdpi.com
Introduction: Community-acquired pneumonia (CAP) presents high mortality rates and high
healthcare costs worldwide. C-reactive protein (CRP) has been widely used as a biomarker …

A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system

A Rezabakhsh, SR Sadat‐Ebrahimi… - Journal of Cellular …, 2022 - Wiley Online Library
Based on the recent reports, cardiovascular events encompass a large portion of the
mortality caused by the COVID‐19 pandemic, which drawn cardiologists into the …

Recomendações para o manejo da pneumonia adquirida na comunidade 2018

RA Corrêa, AN Costa, F Lundgren… - Jornal Brasileiro de …, 2018 - SciELO Brasil
RESUMO A pneumonia adquirida na comunidade (PAC) constitui a principal causa de
morte no mundo. Apesar da vasta microbiota respiratória, o Streptococcus pneumoniae …

2018 recommendations for the management of community acquired pneumonia

RA Corrêa, AN Costa, F Lundgren… - Jornal Brasileiro de …, 2018 - SciELO Brasil
Community-acquired pneumonia (CAP) is the leading cause of death worldwide. Despite
the vast diversity of respiratory microbiota, Streptococcus pneumoniae remains the most …

Comparative analysis of CRP as a biomarker of the inflammatory response intensity among common viral infections affecting the lungs: COVID-19 versus influenza A …

T Levinson, A Wasserman, S Shenhar-Tsarfaty… - Clinical and …, 2023 - Springer
Severe acute respiratory syndrome-corona virus 2 (SARS-CoV-2) is associated with
significant morbidity and mortality. C-reactive protein (CRP) is a useful inflammatory …